| Application no. and date | 03731335.0 (espacenet) (Federated) (European Patent Register), 20030521 | | Patent/reg. no. and date | DK/EP 1534390, 20091223 | | Publication date | 20050601 | | Priority no. and date | US 382871 P, 20020522 | | EP pub. no. and date |
EP 1534390 20050601 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 153693 | | Inventor | MOORE, Stephen, Old Powdermills,
Powdermill Lane,
Leigh
Tonbridge,
Kent TN11 9AN, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/4152 (2006.01) , A61P 7/02 (2006.01) , C07D 231/08 (2006.01) | | Title | 3'- (2Z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidinhydrazino-2'-hydroxy-1,1'-biphenyl-3-carboxylsyre-bis-(monoethanolamin) | | Int. application no. | US2003016255 | | Int. publication no. | WO2003098992 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
